Is Hyaluronic Acid Safe? What the Evidence Covers
Hyaluronic acid is safe in the sense that the molecule itself is familiar to the body — it is a polysaccharide your own tissues synthesise. It is not safe in the sense that every product containing it, or every way of using it, carries the same risk. Those two statements are not in tension. The honest answer depends on which hyaluronic acid product is being discussed, what regulatory route it took, and who is handling it.
This page separates the question into the parts that actually have different answers: four product categories that share one name, the evidence behind the biocompatibility claim, the risk profile the regulator publishes for injectable gels, and the product-level failures that cause most of the harm reported in practice.
Key takeaways
• "Hyaluronic acid" covers four product families on four regulatory routes. Safety claims do not transfer between them.
• Cross-linked HA fillers are regulated as medical devices in the United States, and approved for defined facial uses in adults aged 22 and older.
• Most HA fillers are made by bacterial fermentation rather than animal extraction, chosen partly to reduce allergenic protein exposure.
• HA is the only filler family that can be enzymatically dissolved with hyaluronidase, which changes the failure mode of the whole category.
• The serious adverse events the FDA lists are injection-related, not material-related — which is why product documentation and practitioner qualification are the two controllable variables.
In this article
Four products, one name · Why the material is tolerated · Topical HA · Injectable HA fillers
Reversibility · Who should not be treated · Where the real harm comes from
What makes safety verifiable · Auro Secret documentation · FAQ
Four Products Share One Name
Most confusion in this topic comes from answering a question about one category with evidence from another. A serum cannot inherit a filler's safety record, and a joint injection cannot vouch for a device cleared for the tear trough.
| Category | Form | Regulatory route (US) | Risk scale |
|---|---|---|---|
| Cosmetic | Serums, creams, masks | Cosmetic regulation; no pre-market approval | Low; irritation possible |
| Injectable filler | Cross-linked HA gel, often with lidocaine | Medical device, FDA-cleared for specific indications | Low to serious; procedure-dependent |
| Ophthalmic viscoelastic | Sterile solution used during surgery | Device, used by a surgeon in theatre | Controlled by setting |
| Intra-articular | Hylan / HA preparations for the joint | Device or drug-combination product | Controlled by setting |
The rest of this article is about the second row: cross-linked hyaluronic acid dermal filler, the product class AuroThread manufactures. Statements about it should not be read across to a serum, and a serum's record should not be borrowed to reassure a buyer about a gel.
Why the Material Is Tolerated
Hyaluronic acid is not a foreign polymer. It is a glycosaminoglycan present in skin, connective tissue and synovial fluid, which is why the body does not mount the kind of response it mounts against a permanent synthetic. That is the real basis of the safety reputation — not a marketing claim.
Fermentation replaced animal extraction for a reason
Early hyaluronic acid was extracted from animal tissue, rooster combs being the classic source. The peer-reviewed review of HA filler rheology describes the shift toward bacterial fermentation production, which removes most of the animal protein that drove allergic potential and gives a more reproducible raw material. For a buyer, the practical reading is that "non-animal origin" on a technical file is a safety statement, not an ethical one.
Cross-linking is what has to be controlled
Native HA disappears from tissue in days. A filler must therefore be stabilised, and the industry-standard stabiliser is BDDE (1,4-butanediol diglycidyl ether), which links HA chains into a gel network. The cross-linking reaction is what makes the product last; unreacted residue from the reaction is what has to be removed.
So the material question a buyer should ask is never "is BDDE used" — in most HA fillers it is — but how much residue remains, and is it measured per batch. Regulators cap residual unreacted BDDE; a specification that mentions the limit but supplies no number is incomplete. This is discussed further in the technical guide to HA fillers.
Stocking this category? The safety record of a gel is only as good as its file. AuroThread supplies the grade-level technical sheet — HA origin, concentration by viscosity grade, particle size and count, needle and cannula compatibility, sterilisation method, storage and shelf life.
Request the HA technical data sheet · How to choose an HA filler
Topical Hyaluronic Acid
Cosmetic HA — serums, creams, masks — sits under cosmetic regulation. There is no pre-market clearance equivalent to a device approval, which means the safety profile rests on formulation quality rather than regulatory review.
Adverse events are correspondingly limited: local irritation or contact sensitivity in a minority of users, usually attributable to another ingredient in the formulation rather than to HA itself. The practical risk in this category is a label that overstates what a cosmetic can do, not a clinical complication. This page is not about that category beyond noting the distinction, because buyers routinely conflate the two documents.
Injectable HA Fillers: What the Regulator Publishes
This is where an honest safety discussion has to be specific. The FDA's patient guidance sets out filler risks in three tiers, and the tiers matter because they have different causes.
| Tier | What is reported | Primary driver |
|---|---|---|
| Common | Bruising, redness, swelling, pain, tenderness, itching, rash at the site | Needle trauma and inflammation — expected, self-limiting |
| Less common | Inflammation near the site after illness, vaccination or dental work; nodules or granulomas; infection; open or draining wounds; allergic reaction; tissue death (necrosis) | Immune response, placement depth, contamination or over-correction |
| Most serious | Unintended injection into or pressure on a blood vessel, which can lead to skin necrosis, stroke or blindness | Anatomical knowledge and injection technique |
Read as a set, the pattern is consistent: the serious risks in this category are procedure risks, not material risks. They arise from where the gel is placed, not from what the gel is made of. That is also why a "high-purity HA" claim alone does not constitute a safety argument.
Two further regulator statements belong in any honest version of this page. Fillers are approved for defined indications in adults aged 22 and older, and approval is indication-specific — a cleared material does not license every use of it. And the FDA states that the safe use of dermal fillers in combination with Botox and other treatments has not been evaluated in clinical studies, even though combined treatment is common in practice.
The One Safety Property Unique to HA
Hyaluronic acid is the only filler family with a reversal agent. Hyaluronidase is an enzyme that breaks the HA polymer down, and it is used clinically both to correct an unsatisfactory result and to manage complications.
This changes the failure mode of the category. A misplaced permanent filler stays misplaced. A misplaced HA filler can in principle be reduced or removed, which is one reason HA accounts for the majority of the filler market and why clinics that treat only one material family tend to standardise on this one.
Two limits belong in the same paragraph. Reversal is a clinical intervention with its own risks and its own training requirement — it is not a wipe-clean guarantee. And the FDA also warns that removal of some fillers can be difficult or impossible, a statement aimed at non-HA and permanent materials but one buyers should hear before assuming reversibility extends across a whole portfolio.
Who Should Not Be Treated
This is a clinician's decision, not a content decision. The regulator-supplied boundaries are nonetheless specific enough to be worth stating, because they are the ones most often ignored in grey-market marketing.
Boundaries the FDA sets
Approved HA filler indications are for people aged 22 and older. There is no approved use in younger patients. The agency separately warns that fillers are prescription products and that buying injectables sold directly to the public is unsafe.
Situations a practitioner screens for
Active skin infection or inflammation at the intended site; a history of severe allergic reactions or a known sensitivity to any component of the product; and, for botulinum toxin specifically, pregnancy or lactation, where the FDA notes safety has not been established. For fillers, safety during pregnancy is likewise not established by the clinical programmes supporting clearance, which is why it is treated as an exclusion in practice.
A clinic that does not screen is a liability exposure for whoever supplied it. That is a procurement point, not a clinical one, and it is why the training and after-support a manufacturer offers belongs in the same evaluation as the gel itself.
Where Most of the Real Harm Comes From
Within the regulated channel, the reported serious events are procedure-related. Outside it, the risk profile is different in kind, and the FDA names the specific failure modes.
Four explicit regulatory warnings
- The FDA has not approved injectable silicone or silicone gel for injection to fill wrinkles or augment tissue anywhere in the body.
- The FDA has not approved any injectable filler for body contouring, and warns against injection into the breasts, buttocks or the spaces between muscles because of serious injury including death.
- The FDA has not approved any needle-free device for injecting dermal fillers.
- Injectable fillers are prescription products; buying them where they are sold directly to the public is unsafe.
For a distributor these four lines are also a commercial filter. A supplier whose catalogue lists breast, buttock or body-contouring applications, or who sells to unlicensed buyers, is describing a product set that cannot be defended in a regulated market — regardless of how the gel itself performs.
AuroThread's dermal fillers are presented for facial use. Non-surgical body contouring is explicitly outside what this range claims, and a buyer looking for that application will not find it here.
Evaluating a supplier? Ask for four documents before any price conversation: CE certificate with notified body number, ISO 13485 scope, a lot-linked certificate of analysis, and the stability statement covering 2–25 °C transport.
Request the document set · Dermal fillers: the complete guide
What Makes Safety Verifiable
"Safe" is not a test result. What a buyer can verify is whether the claims behind a product are documented, batch-linked and consistent with the market being sold into. Six items separate a real technical file from a brochure.
| Item | What a complete answer looks like |
|---|---|
| Certification | Certificate number, classification, issuing notified body, scope and expiry date |
| Source of HA | Non-animal, bacterial fermentation; stated explicitly |
| Cross-linking | Agent identified, residual limit stated, and the measured value reported per batch |
| Sterility | Method named (moist heat terminal sterilisation, or equivalent), with packaging format |
| Endotoxin | Non-pyrogenic claim supported by batch testing, not by the sterilisation step alone |
| Traceability | Lot code on each unit, retrievable against a certificate of analysis |
Storage and shelf life complete the picture because they determine whether the documentation still describes the syringe when it arrives. The Auro Secret range is specified at 2–25 °C, away from direct sunlight, do not freeze, with a 2-year shelf life from the manufacturing date — figures that matter for a shipment crossing two climate zones.
How Auro Secret Documents These Points
The range is a non-animal-origin, BDDE cross-linked HA family manufactured under CE marking, ISO 13485 and GMP, with a GMP facility and full traceability from raw HA powder to the finished sterile syringe. Sterilisation is a moist heat terminal process at 121 °C, with each syringe individually packaged. HA concentration is stated as 20–24 mg/mL depending on viscosity grade, and residual BDDE is specified as below the regulatory threshold.
Two specification fields are not published on the current product pages and are deliberately left out here rather than estimated: the residual BDDE value in parts per million, and whether a given SKU contains lidocaine and at what concentration. Both belong in a certificate of analysis and both can be supplied on request. See also the Auro Secret Plus and long-lasting product pages for grade-level specification.
Auro Secret Plus
Cross-linked HA · 20–24 mg/mL by grade · terminal steam sterilisation 121 °C
CE marked, ISO 13485 and GMP manufactured, individually packaged, stored 2–25 °C.
View Product
Auro Secret Plus — Long Duration
Same HA family · longer stated duration · 1 / 2 / 3 / 10 mL formats
Batch documentation, certificate of analysis and certification set available on request.
View ProductFrequently Asked Questions
Is hyaluronic acid safe for everyone?
The molecule is naturally present in the body, which is why tolerance is generally good. Approved injectable indications are limited to adults aged 22 and older, and suitability is screened by a practitioner — active infection at the site, known sensitivity to a component, and a history of severe allergic reactions are the standard exclusions.
Can you be allergic to a hyaluronic acid filler?
It is uncommon. Modern HA is produced by bacterial fermentation rather than extracted from animal tissue, which removes most of the protein load that drove older allergic reactions. Reactions still occur, and lidocaine in a pre-mixed formulation is a separate potential allergen from the HA itself.
Are HA fillers FDA approved?
They are regulated as medical devices and cleared for specific facial indications, not for the general use of the material. The FDA maintains a list of approved dermal fillers, and clearance is indication-specific: a cleared material does not license every anatomical use of it.
Can a hyaluronic acid filler be dissolved?
Yes — hyaluronidase breaks the HA polymer down and is used both for aesthetic correction and for complication management. It is a clinical intervention in its own right, not a cosmetic undo button, and reversibility does not extend to non-HA or permanent fillers.
How long does a hyaluronic acid filler last?
The FDA describes HA fillers as lasting approximately 6 to 12 months. Manufacturers may state wider ranges for specific grades — AuroThread's HA grade pages state 6 to 18 months across four particle sizes. Treat the regulatory figure, the manufacturer figure and the individual result as three different numbers rather than one.
Is hyaluronic acid safe during pregnancy or breastfeeding?
For injectable fillers this is not established, which is why it is treated as an exclusion in practice. For a cosmetic serum the question belongs to the product's own labelling and to a clinician, not to a manufacturer's website. This page does not give individual advice.
What should a buyer verify before ordering HA filler?
Six items: certification with classification, notified body and expiry; HA origin stated as non-animal fermentation; cross-linking agent with a residual limit and a measured batch value; named sterilisation method; endotoxin testing; and lot-level traceability against a certificate of analysis. If any of the six is answered with a marketing adjective rather than a document, the file is incomplete.
Are hyaluronic acid fillers permanent?
No. Cross-linked HA degrades through enzymatic and chemical hydrolysis, more slowly than native HA but progressively. The FDA's approved-filler list places HA in the absorbable families; the single non-absorbable filler it recognises is PMMA. A product marketed as a permanent HA filler is describing something that does not exist.
Can hyaluronic acid be injected anywhere on the body?
No, and this is one of the clearest regulatory lines in the category. The FDA states that no injectable filler is approved for body contouring and warns specifically against injection into the breasts, buttocks or intermuscular spaces because of serious injuries including death. Approved indications are facial, with one hand indication, in adults aged 22 and older.
Why do safety answers online contradict each other?
Because most answers silently switch between the four categories in the table above. A claim true of a serum is quoted for a gel; a complication of an injection is attributed to the molecule. Fixing the category first is the only way to make the question answerable.
Verify the specification rather than the claim? The Auro Secret documentation set covers CE certification with notified body, ISO 13485 scope, sterilisation method, storage and shelf life, and a lot-linked certificate of analysis.
Request the certification and CoA set · Browse the Auro Secret range
